Cabozantinib in Patients With Locally Advanced or Metastatic Urothelial Cell Carcinoma.
Clinical trial NCT04066595 · TERMINATED
Trial details
- NCT number
- NCT04066595
- Sponsor
- Johannes Gutenberg University Mainz
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-10
- Primary completion
- 2021-07-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.